UniQure readout tests durability of benefits, an AI effort to manage heart failure, and more biotech news from The Readout INA FASSBENDER/AFP via Getty Images Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we look at how regulators are trying to keep pace with agentic medical AI, see the FDA launch a project to examine why pregnancy registries struggle with enrollment, and more. Someone out there cure asthma, eh? It sucks. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe Meghana Keshavan covers biotech and contributes to The Readout newsletter.
STAT+: FDA expands Bayer lung cancer drug approval
Full Article
Original Source
Read the full article at Statnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.